| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-08 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |